Ibex Investors’s Danimer Scientific, Inc. DNMR Stock Holding History

Ibex Investors’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-675	Closed	-$676K	–	59
2021 Q2	$676K	Buy	+675	New	+$673K	0.25%	43

Other funds holding DNMR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Ibex Investors's DNMR Position: Q3 2021 in Review

Ibex Investors sold out of Danimer Scientific, Inc. (DNMR) in Q3 2021, closing a stake of 675 shares — an estimated $676K sold.

Ibex Investors first reported a position in DNMR in Q2 2021 and held it in 1 quarter. The position peaked at $676K in Q2 2021. 185 funds tracked by Wall St. Rank hold DNMR as of Q3 2021.

Ibex Investors reported no remaining Danimer Scientific, Inc. position as of Q3 2021 after selling out during the quarter.
Ibex Investors sold 675 Danimer Scientific, Inc. shares in Q3 2021, an estimated $676K.
Ibex Investors first reported a position in Danimer Scientific, Inc. in Q2 2021 and held it in 1 quarter.
Ibex Investors's Danimer Scientific, Inc. position peaked at $676K in Q2 2021.
185 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q3 2021.

Based on Ibex Investors's 13F filing for Q3 2021, filed 5 Nov 2021.